Skip to main content
C4 Therapeutics, Inc. logo

C4 Therapeutics, Inc. — Investor Relations & Filings

Ticker · CCCC ISIN · US12529R1077 US Manufacturing
Open in API
Filings indexed 497 across all filing types
Latest filing 2021-11-30 Regulatory Filings
Country US United States of America
Listing US CCCC

About C4 Therapeutics, Inc.

https://c4therapeutics.com/

C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of a new class of small-molecule medicines through targeted protein degradation (TPD). The company's proprietary TORPEDO (Target Oriented Protein Degrader Optimizer) platform is utilized to create therapeutics that selectively destroy disease-causing proteins. C4 Therapeutics' primary focus is on developing treatments for cancer and other diseases. Its clinical pipeline includes investigational candidates such as cemsidomide (CFT7455) for hematologic malignancies, CFT8919 for solid tumors with specific genetic mutations, and CFT1946 for BRAF V600 mutant cancers.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement, specifically a lease amendment for office and laboratory space. There are no financial statements or detailed financial performance data included, only a description of the lease terms and obligations. This type of filing is an announcement of a significant event rather than a full financial report or earnings release. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not related to board changes, voting results, or legal proceedings. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings like Form 8-K that announce material events but do not contain detailed financial data or reports themselves. The document length and content support this classification with high confidence.
2021-11-30 English
FORM 4 SUBMISSION
Director's Dealing
2021-11-19 English
S-3ASR
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used by companies to register securities for sale to the public. It includes a base prospectus and a sales agreement prospectus for offerings of common stock, preferred stock, debt securities, warrants, and units. The document is not a financial report, earnings release, or management discussion, but rather a regulatory filing related to capital raising activities. It is a detailed registration statement under the Securities Act of 1933, not an announcement or summary. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2021-11-10 English
10-Q
Interim / Quarterly Report Q3 2021
2021-11-10 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 10, 2021, for C4 Therapeutics, Inc. It specifically mentions Item 2.02 "Results of Operations and Financial Condition" and states that the company issued a press release announcing financial results and business highlights for the quarter ended June 30, 2021. The document includes a press release as Exhibit 99.1. The text clarifies that the information is being furnished and is not "filed" for purposes of Section 18 of the Exchange Act, indicating this is an initial announcement rather than a full detailed report. The document length is 3749 characters, which is relatively short and consistent with a press release or earnings announcement rather than a full quarterly or annual report. Therefore, this document is best classified as an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only.
2021-11-10 English
FORM 4 SUBMISSION
Director's Dealing
2021-10-15 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.